Amgen
Amgen Inc., a leading biotechnology company headquartered in the United States, has been at the forefront of innovation since its founding in 1980. With a strong presence in major operational regions including Europe and Asia, Amgen focuses on developing therapies in areas such as oncology, nephrology, and inflammation. Renowned for its pioneering biologic medicines, Amgen's core products include Enbrel, Neulasta, and Prolia, which are distinguished by their ability to target specific disease pathways effectively. The company has achieved significant milestones, including the introduction of the first recombinant human erythropoietin, Epogen, which transformed the treatment of anaemia. As a prominent player in the biotechnology industry, Amgen continues to excel, holding a strong market position and receiving numerous accolades for its commitment to scientific excellence and patient care.
DitchCarbon Score
How does Amgen's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amgen's score of 39 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Amgen's reported carbon emissions
In 2023, Amgen reported significant carbon emissions, with total Scope 1 emissions reaching approximately 153,000,000 kg CO2e and Scope 2 emissions at about 12,000,000 kg CO2e. The company has set ambitious targets to reduce its greenhouse gas emissions, committing to a 55% reduction in absolute Scope 1 and 2 emissions by 2027, using 2019 as the baseline year. Additionally, Amgen aims to transition to 100% renewable electricity sourcing by 2027, up from 29% in 2019, and maintain this commitment through 2030. Furthermore, the company plans for 73% of its suppliers, by spend, to have science-based targets by 2027. These initiatives align with industry standards for climate action and demonstrate Amgen's commitment to sustainability and reducing its environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2023 | |
|---|---|---|
| Scope 1 | 84,000,000 | 000,000,000 |
| Scope 2 | 354,000,000 | 00,000,000 |
| Scope 3 | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Amgen is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
